Cancer
短名 | |
Journal Impact | 5.93 |
国际分区 | ONCOLOGY(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 0008-543X, 1045-7410, 1097-0142 |
h-index | 340 |
国内分区 | 医学(2区)医学肿瘤学(2区) |
Top期刊 | 是 |
CANCER 网站是 CANCER(美国癌症协会的跨学科国际期刊)和 CANCER CYTOPATHOLOGY(美国癌症协会的期刊)的全文电子实施。 CANCER 根据但不限于以下疾病部位和学科发布跨学科肿瘤学信息:血液/骨髓;乳腺疾病;内分泌失调;流行病学;胃肠道;泌尿生殖系统疾病;妇科肿瘤学;头颈部疾病;肝胆道;综合医学;肺部疾病;医学肿瘤学;神经肿瘤学;病理学放射肿瘤学;转化研究
期刊主页投稿网址涉及主题 | 医学生物内科学遗传学病理癌症外科化学免疫学肿瘤科放射科生物化学 |
出版信息 | 出版商: John Wiley and Sons Inc,出版周期: Semimonthly,期刊类型: journal |
基本数据 | 创刊年份: 1948,原创研究文献占比: 92.35%,自引率:1.60%, Gold OA占比: 20.09% |
平均审稿周期 | 网友分享经验:很快,2-3周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology
2024-9-17
Reply to “The influence of multivitamin intake on survival patterns in patients with colorectal cancer”
2024-9-15
Focus on fertility in female adolescents and young adults with cancer
2024-9-15
New advances in the role of <i>JAK2</i> V617F mutation in myeloproliferative neoplasms
2024-9-14
The influence of multivitamin intake on survival patterns in patients with colorectal cancer
2024-9-14
Risk scores predicting disease progression in early‐stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
2024-9-12
All that can still be done: Communicating with precision and patient‐centeredness when recommending hospice initiation for cancer patients
2024-9-10
Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary
2024-9-10
The impact of a small‐group mammography video discussion on promoting screening uptake among nonadherent Chinese American immigrant women: A randomized controlled trial
2024-9-10
Tailoring language for genitourinary function in patients with newly diagnosed prostate cancer to facilitate discussions in diverse populations and overcome health literacy barriers
2024-9-10
Reply to “Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary”
2024-9-10
Genitourinary cancer and family: The reverberating psychological and cardiovascular effects of a genitourinary cancer diagnosis on first‐degree relatives and spouses
2024-9-9
Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone
2024-9-6
Imatinib adherence prediction using machine learning approach in patients with gastrointestinal stromal tumor
2024-9-6
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
2024-9-6
Expression of Concern
2024-9-5
Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis
2024-9-5
Critical analysis of Reiner et al.'s study on agreement of medical record abstraction and self‐report of breast cancer treatment
2024-9-4
Sociodemographic and geographic factors impacting radiotherapy recommendation, initiation, and completion for patients with cancer
2024-9-4
Reply to “Critical analysis of Reiner et al.'s study on agreement of medical record abstraction and self‐report of breast cancer treatment”
2024-9-4
Multitargeted therapy is safe and leads to durable remission of DLBCL
2024-9-3
Issue Information
2024-9-3
Durable efficacy with fixed‐duration BTKi and venetoclax for CLL
2024-9-3
Durvalumab not cost‐effective with current pricing strategies for stage III NSCLC
2024-9-3
Erratum to “Chimeric antigen receptor–based immunotherapy in breast cancer: Recent progress in China”
2024-8-30
Generative artificial intelligence as a source of breast cancer information for patients: Proceed with caution
2024-8-30
Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials
2024-8-28
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes
2024-8-27
Multidimensional structural racism and estimated cancer risk from traffic‐related air pollution
2024-8-26
Androgen deprivation therapy and postprostatectomy radiation: What is the optimal duration?
2024-8-25
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board
2024-8-25
When destiny doesn’t pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan
2024-8-25
Issue Information
2024-8-24
Promising new treatment shows potential for high‐risk bladder cancer
2024-8-24
Using AI to tailor cancer care and drug discovery
2024-8-24
First person profile
2024-8-24
Effect of body mass index on the prognosis of children and adolescents with high‐grade mature B‐cell non‐Hodgkin lymphoma
2024-8-22
Clonal hematopoiesis and solid tumor risk: New insights from the Women’s Health Initiative
2024-8-20
Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries
2024-8-20
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake
2024-8-19
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls
2024-8-19
Comparison of incident breast cancer cases in the largest national US tumor registries
2024-8-18
Enhancing the role of social work in managing cancer risks among LGBTQ+ populations
2024-8-18
The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure equity of care
2024-8-18
Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium
2024-8-18
Continuity and coordination of care for childhood cancer survivors with multiple chronic conditions: Results from the Childhood Cancer Survivor Study
2024-8-18
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure equity of care”
2024-8-18
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远